Is Erosive Gastritis with Mild Intestinal Metaplasia Serious?

Erosive gastritis with mild intestinal metaplasia is generally not considered a severe condition. During the healing process of the gastric mucosa in patients with erosive gastritis, intestinal metaplasia may occur as part of the repair mechanism. In most cases, this type of gastritis is associated with Helicobacter pylori infection. If the infection is detected and treated early, the gastric mucosa has a good chance of recovery.

Early intervention can lead to significant improvement or even full recovery. When erosive gastritis with intestinal metaplasia occurs before the development of atrophy or more advanced changes, appropriate treatment can often reverse the damage. Therefore, timely medical attention and treatment are highly recommended to achieve the best possible outcome.

Patients diagnosed with erosive gastritis and intestinal metaplasia should undergo testing for Helicobacter pylori. If the infection is present, eradication therapy is strongly advised. In addition, doctors may prescribe medications that promote gastric mucosal healing, such as teprenone, sofalcone, or polaprezinc. These drugs not only protect the mucosal lining but also stimulate epithelial cell proliferation, enhance blood flow and nutrient supply to the stomach lining, improve local immunity, and support the secretion of gastrointestinal-related hormones.

Most patients respond well to this comprehensive treatment approach. With proper management, including bacterial eradication and mucosal protection therapy, the symptoms of erosive gastritis with mild intestinal metaplasia can often be effectively controlled or resolved.